Chapter 4 - Organic nanocarriers for brain drug delivery
Although the blood–brain barrier remains a major barrier to drug delivery, organic nanocarriers (ONCs) have been demonstrated to be effective in targeting and delivering therapeutic agents to the brain and have provided promising preclinical outcomes. Because of their favourable physicochemical prop...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , |
| Formato: | bookPart |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10284/10207 |
| País: | Portugal |
| Oai: | oai:bdigital.ufp.pt:10284/10207 |